The Cardiovascular Research Foundation And The Angiographic Core Laboratory Of Harvard Medical Faculty Physicians At Beth Israel Deaconess Medical Center, Inc. Announce CRFiCOR, A Collaborative Alliance To Enhance Patient Care
CRFiCOR's comprehensive cardiovascular imaging laboratories to set new standards for expert clinical research support
The Angiographic and Imaging Core Laboratories of the Clinical Trials Center (CTC) at the Cardiovascular Research Foundation (CRF) in New York have formed a collaborative alliance with the Angiographic Core Laboratory of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, Inc. (HFMP). Led by distinguished physicians Gregg W. Stone, Jeffrey J. Popma and Gary S. Mintz, the collaborative research alliance will be known as CRFiCOR.
CRFiCOR is now united in contracting and performing research projects at its New York City and Boston campuses to provide expert clinical research support and comprehensive imaging Core Lab services for trial sponsors, investigators and hospitals. The new CRFiCOR alliance, as part of the CRF Clinical Trials Center, will specialize in all aspects of core laboratory analysis, including coronary angiography, carotid and peripheral angiography, intravascular imaging and structural heart disease assessment (including valve interventions), as well as electrocardiography, CT and MR imaging.
CRF's Angiographic and Imaging Core Laboratories are one of the world's leading centers for independent investigation, having performed highly complex analyses for hundreds of trials over the last 2 decades. HMFP's Angiographic Core Laboratory has performed independent angiographic analyses and interpretations for 14 years in Boston. Collectively, CRFiCOR has performed imaging studies in more than 100,000 patients.
"I am delighted to once again be working with the skilled and talented physician researchers at CRF. Our combined depth of experience on upcoming research projects will provide even more comprehensive clinical research support for our clients," said Jeffrey J. Popma, MD, Director of HMFP's Angiographic Core Laboratory and Associate Professor of Medicine at Harvard Medical School. Dr. Popma established CRF's Angiographic Core Laboratory (ACL) in Washington, DC in 1992.
"We are excited to be working again with Jeff Popma and his distinguished colleagues at HMFP's Angiographic Core Laboratory to take these comprehensive services to the next level" said Gary S. Mintz, MD, Chief Medical Officer of the Cardiovascular Research Foundation. "We regard this exciting new initiative, which integrates multiple imaging modalities and advanced information technology initiatives, as a vision for the future," he said.
"CRFiCOR, with its progressive physician leadership, has been designed to set a new standard of quality, sophistication and responsiveness for the support of studies to improve patient outcomes in cardiovascular medicine," said Gregg W. Stone, MD, Co-Director of the Medical Research and Education Division at CRF and Director of the CRF Clinical Trials Center. He is also Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center.
About CRF
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies, drugs and therapies in the subspecialty of interventional cardiology and endovascular medicine.
The CRF Clinical Trials Center (CTC) is a global full-service academic research organization, providing comprehensive clinical trial design, evaluation, and analysis services through its Core Laboratories, which perform independent analyses and interpretations, including Angiography, Intravascular Imaging (IVUS, OCT, NIRS), and Non-invasive Imaging and Assessment (ECG, CT and MRI). In addition, the CRF Clinical Trials Center has a Data Coordinating and Analysis Center offering comprehensive data coordination, biostatistics, regulatory support and publication services, as well as a Clinical Events Committee and Data Safety Monitoring Board formulation and management. For more information, visit www.crf.org.
About The HMFP Angiographic Core Laboratory
First established in Boston in 1998, the Angiographic Core Laboratory was the central analysis laboratory for a variety of drug eluting stents, distal protection devices, carotid stenting and peripheral vascular intervention angiographic studies. The Angiographic Core Laboratory relocated to Beth Israel Deaconess Medical Center in 2009, and has been operated by HMFP since 2010. During that time, it has continued its critical work as an analysis center for coronary and peripheral intervention studies.
SOURCE: Cardiovascular Research Foundation